Nemocnice Rudolfa a Stefanie
About Nemocnice Rudolfa a Stefanie
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Nemocnice Rudolfa a Stefanie
During the past decade, Nemocnice Rudolfa a Stefanie conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 4 clinical trials were completed, i.e. on
average, 133.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Monitoring of Safety and Tolerance of PICOPREP in Clinical Practice
2012-05-01
2015-02-01
Terminated
3,324
Avelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor)
2013-01-31
2019-12-16
Completed
1,756
Avelumab in Third-Line Gastric Cancer (JAVELIN Gastric 300)
2015-12-28
2019-11-13
Completed
371
Preventive Treatment of Oxaliplatin Induced Peripheral Neuropathy in Metastatic Colorectal Cancer (POLAR-M)
2018-11-07
2020-08-31
Terminated
291
Preventive Treatment of OxaLiplatin Induced peripherAl neuRopathy in Adjuvant Colorectal Cancer
2019-01-07
2020-08-31
Terminated
301
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Nemocnice Rudolfa a Stefanie"
#1 collaborator was "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator and "Solasia Pharma K.K." with 2 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Nemocnice Rudolfa a Stefanie
According to Clinical.Site data, the most researched conditions in "Nemocnice Rudolfa a Stefanie" are
"Chemotherapy-induced Peripheral Neuropathy" (2 trials), "Colorectal Cancer" (2 trials), "Bowel Cleanliness" (1 trials), "Gastric Cancer Third Line" (1 trials) and "Nocturia" (1 trials). Many other conditions were trialed in "Nemocnice Rudolfa a Stefanie" in a lesser frequency.
Clinical Trials Intervention Types at Nemocnice Rudolfa a Stefanie
Most popular intervention types in "Nemocnice Rudolfa a Stefanie" are "Drug" (4 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Avelumab" (2 trials), "Calmangafodipir (5 µmol/kg)" (2 trials), "Placebo" (2 trials), "Best Supportive Care (BSC)" (1 trials) and "Calmangafodipir (2 µmol/kg)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Nemocnice Rudolfa a Stefanie
The vast majority of trials in "Nemocnice Rudolfa a Stefanie" are
6 trials for "All" genders.
Clinical Trials Status at Nemocnice Rudolfa a Stefanie
Currently, there are NaN active trials in "Nemocnice Rudolfa a Stefanie".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Nemocnice Rudolfa a Stefanie,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Nemocnice Rudolfa a Stefanie, 1 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".